Cargando…
Management of Plasmodium vivax risk and illness in travelers
Malaria poses an exceptionally complex problem for providers of travel medicine services. Perceived high risk of exposure during travel typically prompts prescribing protective antimalarial drugs. Suppressive chemoprophylactic agents have dominated strategy for that practice for over 70 years. This...
Autor principal: | Baird, J. Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531091/ https://www.ncbi.nlm.nih.gov/pubmed/28883977 http://dx.doi.org/10.1186/s40794-017-0049-x |
Ejemplares similares
-
Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency
por: Baird, J. Kevin
Publicado: (2015) -
Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria
por: Baird, J. Kevin
Publicado: (2013) -
Attacking Plasmodium vivax
por: Baird, J. Kevin
Publicado: (2016) -
Pernicious and Threatening Plasmodium vivax as Reality
por: Baird, J. Kevin
Publicado: (2014) -
Epidemiology of Plasmodium vivax in Indonesia
por: Surjadjaja, Claudia, et al.
Publicado: (2016)